Wang, S.; Malebari, A.M.; Greene, T.F.; Kandwal, S.; Fayne, D.; Nathwani, S.M.; Zisterer, D.M.; Twamley, B.; O’Boyle, N.M.; Meegan, M.J.
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000.
https://doi.org/10.3390/ph16071000
AMA Style
Wang S, Malebari AM, Greene TF, Kandwal S, Fayne D, Nathwani SM, Zisterer DM, Twamley B, O’Boyle NM, Meegan MJ.
Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals. 2023; 16(7):1000.
https://doi.org/10.3390/ph16071000
Chicago/Turabian Style
Wang, Shu, Azizah M. Malebari, Thomas F. Greene, Shubhangi Kandwal, Darren Fayne, Seema M. Nathwani, Daniela M. Zisterer, Brendan Twamley, Niamh M. O’Boyle, and Mary J. Meegan.
2023. "Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells" Pharmaceuticals 16, no. 7: 1000.
https://doi.org/10.3390/ph16071000
APA Style
Wang, S., Malebari, A. M., Greene, T. F., Kandwal, S., Fayne, D., Nathwani, S. M., Zisterer, D. M., Twamley, B., O’Boyle, N. M., & Meegan, M. J.
(2023). Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals, 16(7), 1000.
https://doi.org/10.3390/ph16071000
